Miguel Tovar

With extensive experience in the pharmaceutical business Miguel is a journalist specialised in this sector.

[Sahil Bloom @SahilBloom]

I recently came across data on who we spend our time with over the course of our lives.

The insights are simultaneously inspiring and depressing.

Here are 6 graphs everyone needs to see:

[Denise Silber - BasilStrategies - VRforHealth @health20Paris]

🎙 My new #Harvard #Alumni #Entrepreneurs #podcast is with amazing Rotem Schacham, Principal #ViolaVentures who describes the features required to aspire to #unicorn status + the view from the investor seat 📌https://t.co/SUvrIrk3rR #entrepreneur #startup #israel #startups #tech

[Prof. Akiko Iwasaki @VirusesImmunity]

What an amazing report to wake up to! Pfizer vaccine provided 100% protection in 12-15 year olds (18 cases of infection in the placebo group, and 0 among the children who received the vaccine). The n is small, but gives me so much hope for school opening in the near future. A++

[Prof. Akiko Iwasaki @VirusesImmunity]

Here is my latest interview on @NPR on #LongCovid and how vaccines might help improve symptoms in some but not others.

https://t.co/ZUjiRNp3T1

[Miguel Tovar @blogaceutics]

The mRNA revolution: from Covid-19 to malaria, seasonal flu and cancer. It took Moderna only 48 hours to synthesize the vaccine after the genetic code of SARS-CoV-2 was published. This breakthrough technology could save millions of lives a year.

[Derek Thompson @DKThomp]

I wrote a long piece about mRNA technology

- what makes it so special
- its 40 year history of wandering in the scientific desert
- why it broke thru in 2020
- what it could accomplish next
- and how it epitomizes the real story of scientific progress

https://t.co/DiWxZFCEpK

[Prof. Jose-Luis Jimenez @jljcolorado]

1/ A year ago, @WHO started propagating an enormous error.

Now we know that #COVIDisAirborne, and that surface transmission is low and large droplet transmission is minor.

But @WHO has yet admit this clearly, which continues to create great confusion.

[Matthew Herper @matthewherper]

José Baselga, AstraZeneca oncology R&D head, dies at 61 https://t.co/Sk4m89oOKX

[Endpoints News @endpts]

José Baselga, acclaimed drug hunter, physician and AstraZeneca's pioneering cancer R&D chief, has died

https://t.co/1XxU5zy4C8

[Miguel Tovar @blogaceutics]

Oncologist Josep Baselga dies at 61 | EN24 News https://t.co/OBDPd8QEk1

[Bernat Olle 🇺🇦 @bernatolle]

The Spanish press is saying that Josep Baselga passed away. Hasn’t made it to US press yet. Very sad to hear. He did so much for cancer patients. He had many brilliant ideas that he leaves unfinished. I hope AZ colleagues can pick up the baton. https://t.co/UHNVE84d9y

[Prof. Akiko Iwasaki @VirusesImmunity]

There is an absolute #COVID19 crisis happening in Brazil. We need to send mRNA vaccines encoding the P1 spike ASAP. Can Moderna and Pfizer please help???

[Miguel Tovar @blogaceutics]

Worth reading 👇🏾

[Dave Keating @DaveKeating]

I keep seeing the line 'EU is having vaccine problems because it was too slow in negotiating contracts' repeated in 🇬🇧&🇺🇸 media.

I want to push back on this narrative because I think it's missing where real EU-level mistakes lie. Let's review what happened in past year (🧵1/17)

[Miguel Tovar @blogaceutics]

The curious case of AstraZeneca's Covid-19 vaccine https://t.co/M9y5OJ9cGb

[Miguel Tovar @blogaceutics]

Triastek receives FDA IND clearance for 3D printed drug to treat rheumatoid arthritis - 3D Printing Industry https://t.co/OaAAcrm6Ya

[Miguel Tovar @blogaceutics]

Pfizer says South African variant could significantly reduce protective antibodies | Article [AMP] | Reuters https://t.co/KJ0MKohe2z

[Miguel Tovar @blogaceutics]

Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine | Reuters https://t.co/X5BQmt6gvg

[Miguel Tovar @blogaceutics]

https://t.co/pY6ZYAFQ1C

[Prof. Jose-Luis Jimenez @jljcolorado]

1/ AIR CLEANERS: recommendations from the scientists of what to use and what to avoid

[Miguel Tovar @blogaceutics]

First full results from interim analysis confirm that the Oxford #COVIDー19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease https://t.co/iA96hIgEIN

[Miguel Tovar @blogaceutics]

Want to See the Future of Digital Health Tools? Look to Germany. https://t.co/6h3ylYtLX9